Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma, Non-Hodgkin 3Lung Neoplasms 3Astrocytoma 3Recurrence 2Prostatic Neoplasms 2Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neurofibroma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neurilemmoma 1Neoplasms, Unknown Primary 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mouth Neoplasms 1Mesothelioma, Malignant 1

Interventions

durvalumab 2Radiotherapy 2tremelimumab 1rocakinogene sifuplasmid 1antineoplaston AS 2-1 1antineoplaston A10 1VGX-3100 1Surveys and Questionnaires 1Palliative Care 1Multimodal Imaging 1MEDI0457 1Interviews as Topic 1Immunoglobulin G 1Disulfides 1Device Removal 1Cisplatin 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vulvar Neoplasms × antineoplaston AS 2-1 × Clear all
NCT00003525 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Burzynski Research Institute

Phase 2 Terminated
8 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡